Universal Health Services Stock Forecast, Price & News

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Universal Health Services in the last twelve months. There are currently 4 sell ratings, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Universal Health Services stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in UHS, but not buy additional shares or sell existing shares.
View analyst ratings for Universal Health Services or view top-rated stocks.

11 equities research analysts have issued 12 month price objectives for Universal Health Services' shares. Their UHS stock forecasts range from $115.00 to $185.00. On average, they anticipate Universal Health Services' stock price to reach $146.42 in the next twelve months. This suggests a possible upside of 34.6% from the stock's current price.
View analysts' price targets for Universal Health Services or view top-rated stocks among Wall Street analysts.

Universal Health Services' stock was trading at $129.66 at the beginning of the year. Since then, UHS shares have decreased by 16.1% and is now trading at $108.77.
View the best growth stocks for 2022 here.

Universal Health Services saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 3,600,000 shares, an increase of 32.8% from the May 15th total of 2,710,000 shares. Based on an average daily volume of 703,100 shares, the short-interest ratio is presently 5.1 days. Currently, 5.6% of the company's stock are short sold.
View Universal Health Services' Short Interest.

Universal Health Services is scheduled to release its next quarterly earnings announcement on Monday, July 25th 2022.
View our earnings forecast for Universal Health Services.

Universal Health Services, Inc. (NYSE:UHS) released its quarterly earnings data on Monday, April, 25th. The health services provider reported $2.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.47 by $0.32. The health services provider had revenue of $3.29 billion for the quarter, compared to analysts' expectations of $3.24 billion. Universal Health Services had a trailing twelve-month return on equity of 15.06% and a net margin of 7.25%. The company's quarterly revenue was up 9.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.44 earnings per share.
View Universal Health Services' earnings history.

Universal Health Services announced a quarterly dividend on Wednesday, May 18th. Stockholders of record on Wednesday, June 1st will be paid a dividend of $0.20 per share on Wednesday, June 15th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, May 31st.
View Universal Health Services' dividend history.

Universal Health Services(NYSE:UHS) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.76%. The dividend payout ratio of Universal Health Services is 7.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Universal Health Services will have a dividend payout ratio of 5.96% next year. This indicates that Universal Health Services will be able to sustain or increase its dividend.
View Universal Health Services' dividend history.

Universal Health Services announced that its board has initiated a stock repurchase program on Thursday, February 24th 2022, which allows the company to repurchase $1,400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 12.1% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board believes its stock is undervalued.

Universal Health Services updated its FY 2022 earnings guidance on Monday, April, 25th. The company provided EPS guidance of $11.900-$12.900 for the period, compared to the consensus earnings per share estimate of $12.390. The company issued revenue guidance of $13.42 billion-$13.69 billion, compared to the consensus revenue estimate of $13.52 billion.

237 employees have rated Universal Health Services CEO Alan B. Miller on Glassdoor.com. Alan B. Miller has an approval rating of 63% among Universal Health Services' employees. This puts Alan B. Miller in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Universal Health Services include HCA Healthcare (HCA), Alcon (ALC), Acadia Healthcare (ACHC), Tenet Healthcare (THC), Encompass Health (EHC), The Ensign Group (ENSG), Petco Health and Wellness (WOOF), Select Medical (SEM), U.S. Physical Therapy (USPH), National HealthCare (NHC), Brookdale Senior Living (BKD), Community Health Systems (CYH) and Five Star Senior Living (FVE).
View all of UHS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Universal Health Services investors own include UnitedHealth Group (UNH), Netflix (NFLX), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC), Walt Disney (DIS), Intel (INTC), Johnson & Johnson (JNJ), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

Universal Health Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "UHS."

Universal Health Services' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.50%), BlackRock Inc. (6.72%), First Eagle Investment Management LLC (5.56%), Invesco Ltd. (5.29%), State Street Corp (4.22%) and Wellington Management Group LLP (2.91%). Company insiders that own Universal Health Services stock include Eileen C Mcdonnell, Eileen C Mcdonnell, Elliot J Md Mba Sussman, Lawrence S Gibbs, Marc D Miller, Marc W Booth, Marvin G Pember, Matthew Jay Peterson, Robert H Hotz and Steve Filton.
View institutional ownership trends for Universal Health Services.

UHS stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, JPMorgan Chase & Co., Nordea Investment Management AB, American Century Companies Inc., Boston Partners, Glenview Capital Management LLC, Nuance Investments LLC, and UBS Group AG. Company insiders that have sold Universal Health Services company stock in the last two years include Eileen C Mcdonnell, Elliot J Md Mba Sussman, Lawrence S Gibbs, Marc W Booth, and Matthew Jay Peterson.
View insider buying and selling activity for Universal Health Services or view top insider-selling stocks.

UHS stock was purchased by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Goldman Sachs Group Inc., Vanguard Group Inc., Invesco Ltd., BlackRock Inc., WINTON GROUP Ltd, Principal Financial Group Inc., and Dimensional Fund Advisors LP.
View insider buying and selling activity for Universal Health Services or or view top insider-buying stocks.

Shares of UHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of UHS stock can currently be purchased for approximately $108.77.

Universal Health Services (NYSE:UHS) has a market capitalization of $8.14 billion and generates $12.64 billion in revenue each year. The health services provider earns $991.59 million in net income (profit) each year or $11.409990 on an earnings per share basis.

Universal Health Services employs 89,400 workers across the globe.

Universal Health Services' mailing address is 367 S GULPH RD, KING OF PRUSSIA PA, 19406. The official website for Universal Health Services is www.uhsinc.com. The health services provider can be reached via phone at (610) 768-3300, via email at [email protected], or via fax at 610-768-3336.